Angion Biomedica Corp Stock Fundamentals
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
Angion Biomedica Corp fundamentals help investors to digest information that contributes to Angion Biomedica's financial success or failures. It also enables traders to predict the movement of Angion Stock. The fundamental analysis module provides a way to measure Angion Biomedica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Angion Biomedica stock.
Angion |
Angion Biomedica Corp Company Shares Outstanding Analysis
Angion Biomedica's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Angion Biomedica Shares Outstanding | 30.11 M |
Most of Angion Biomedica's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Angion Biomedica Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Angion Biomedica Corp has 30.11 M of shares currently outstending. This is 83.32% lower than that of the Healthcare sector and 71.82% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 94.73% higher than that of the company.
Angion Biomedica Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Angion Biomedica's current stock value. Our valuation model uses many indicators to compare Angion Biomedica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Angion Biomedica competition to find correlations between indicators driving Angion Biomedica's intrinsic value. More Info.Angion Biomedica Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Angion Biomedica's earnings, one of the primary drivers of an investment's value.Angion Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Angion Biomedica's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Angion Biomedica could also be used in its relative valuation, which is a method of valuing Angion Biomedica by comparing valuation metrics of similar companies.Angion Biomedica is currently under evaluation in shares outstanding category among its peers.
Angion Fundamentals
| Return On Equity | -0.54 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (31.48) % | |||
| Current Valuation | (26.79 M) | |||
| Shares Outstanding | 30.11 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 16.36 % | |||
| Number Of Shares Shorted | 63.65 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 2.3 M | |||
| Gross Profit | (15.8 M) | |||
| EBITDA | (20.12 M) | |||
| Net Income | (38.81 M) | |||
| Cash And Equivalents | 63.37 M | |||
| Cash Per Share | 2.10 X | |||
| Total Debt | 4.2 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 8.47 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (38.39 M) | |||
| Short Ratio | 0.73 X | |||
| Earnings Per Share | (10.11) X | |||
| Target Price | 1.5 | |||
| Beta | 0.6 | |||
| Market Capitalization | 30.11 M | |||
| Total Asset | 52.79 M | |||
| Retained Earnings | (253.94 M) | |||
| Working Capital | 45.06 M | |||
| Current Asset | 18.1 M | |||
| Current Liabilities | 5.28 M | |||
| Z Score | -2.62 | |||
| Net Asset | 52.79 M |
About Angion Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Angion Biomedica Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Angion Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Angion Biomedica Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York. Angion Biomedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 37 people.
Pair Trading with Angion Biomedica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angion Biomedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will appreciate offsetting losses from the drop in the long position's value.Moving against Angion Stock
| 0.85 | CSLLY | CSL | PairCorr |
| 0.79 | CMXHF | CSL Limited | PairCorr |
| 0.77 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.77 | MCAE | Mountain Crest Acqui | PairCorr |
| 0.68 | QSAM | Qsam Biosciences | PairCorr |
The ability to find closely correlated positions to Angion Biomedica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angion Biomedica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angion Biomedica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angion Biomedica Corp to buy it.
The correlation of Angion Biomedica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angion Biomedica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |